CPDM's New Patient Derived Model Creation

CPDM supports the creation of patient derived cell lines (2D, 3D spheroid, or organoid); patient derived xenografts (PDX); as well as acute cell sensitivity to drug models (ACSD) from patient tumors.

Examples of some of our models (left to right): Lung adenocarcinoma organoids, glioblastoma spheroids, subrenal capsule PDX of mesothelioma, and ultrasound detection of an atypical teratoid PDX

Please email models@dfci.harvard.edu to learn more about our model creation services.